Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2007, Article ID 34128, 6 pages
http://dx.doi.org/10.1155/2007/34128
Research Article

Follow up after Primary Treatment of Soft Tissue Sarcoma: A Survey of Current Practice in the United Kingdom

1North of England Bone and Soft Tissue Tumour Service, Freeman Hospital, Newcastle Upon Tyne Hospitals, Newcastle NE7 7DN, UK
2Cancer Research UK Clinical Trials Unit, University of Birmingham, Division of Cancer studies, Edgbaston, Birmingham B15 2TT, UK
3Section of Oncology and Pathology, Division of Genomic Medicine, University of Sheffield, Sheffield S10 2SJ, UK
4Orthopaedic Oncology Service, The Royal Orthopaedic Hospital, Northfield, Birmingham B31 2AP, UK

Received 14 September 2006; Accepted 27 June 2007

Academic Editor: David Spooner

Copyright © 2007 C. H. Gerrand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. E. Pollock, L. H. Karnell, H. R. Menck, and D. P. Winchester, “The National Cancer Data Base report on soft tissue sarcoma,” Cancer, vol. 78, no. 10, pp. 2247–2257, 1996. View at Publisher · View at Google Scholar
  2. J. C. Yang, A. E. Chang, A. R. Baker et al., “Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity,” Journal of Clinical Oncology, vol. 16, no. 1, pp. 197–203, 1998. View at Google Scholar
  3. J. F. Tierney, V. Mosseri, L. A. Stewart, R. L. Souhami, and M. K. B. Parmar, “Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials,” British Journal of Cancer, vol. 72, no. 2, pp. 469–475, 1995. View at Google Scholar
  4. F. C. Eilber, G. Rosen, S. D. Nelson et al., “High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality,” Annals of Surgery, vol. 237, no. 2, pp. 218–226, 2003. View at Publisher · View at Google Scholar
  5. M. W. Kattan, D. H. Y. Leung, and M. F. Brennan, “Postoperative nomogram for 12-year sarcoma-specific death,” Journal of Clinical Oncology, vol. 20, no. 3, pp. 791–796, 2002. View at Publisher · View at Google Scholar
  6. C. S. Trovik, “Local recurrence of soft tissue sarcoma: a Scandinavian sarcoma group project,” Acta Orthopaedica Scandinavica, Supplement, vol. 72, no. 300, pp. 1–31, 2001. View at Publisher · View at Google Scholar
  7. A. L. Beitier, K. S. Virgo, F. E. Johnson, J. F. Gibbs, and W. G. Kraybill, “Current follow-up strategies after potentially curative resection of extremity sarcomas: results of a survey of the members of the society of surgical oncology,” Cancer, vol. 88, no. 4, pp. 777–785, 2000. View at Publisher · View at Google Scholar
  8. A. Goel, M. E. Christy, K. S. Virgo, W. G. Kraybill, and F. E. Johnson, “Costs of follow-up after potentially curative treatment for extremity soft-tissue sarcoma,” International Journal of Oncology, vol. 25, no. 2, pp. 429–435, 2004. View at Google Scholar
  9. F. E. Johnson, K. Sakata, W. G. Kraybill et al., “Long-term management of patients after potentially curative treatment of extremity soft tissue sarcoma: practice patterns of members of the Society of Surgical Oncology,” Surgical Oncology, vol. 14, no. 1, pp. 33–40, 2005. View at Publisher · View at Google Scholar
  10. K. Sakata, A. L. Beitler, J. F. Gibbs, W. G. Kraybill, K. S. Virgo, and F. E. Johnson, “How surgeon age affects surveillance strategies for extremity soft tissue sarcoma patients after potentially curative treatment,” Journal of Surgical Research, vol. 108, no. 2, pp. 227–234, 2002. View at Publisher · View at Google Scholar
  11. K. Sakata, F. E. Johnson, A. L. Beitler, W. G. Kraybill, and K. S. Virgo, “Extremity soft tissue sarcoma patient follow-up: tumor grade and size affect surveillance strategies after potentially curative surgery,” International Journal of Oncology, vol. 22, no. 6, pp. 1335–1343, 2003. View at Google Scholar
  12. Department of Health, 2005, NHS reference costs 2003 and national tariff 2004, Department of Health.
  13. R. Clasby, K. Tilling, M. A. Smith, and C. D. M. Fletcher, “Variable management of soft tissue sarcoma: regional audit with implications for specialist care,” British Journal of Surgery, vol. 84, no. 12, pp. 1692–1696, 1997. View at Publisher · View at Google Scholar
  14. J. Glencross, S. P. Balasubramanian, J. Bacon, M. H. Robinson, and M. W. Reed, “An audit of the management of solf tissue sarcoma within a health region in the UK,” European Journal of Surgical Oncology, vol. 29, no. 8, pp. 670–675, 2003. View at Publisher · View at Google Scholar
  15. M. F. Brennan, “Follow-up is valuable and effective: true, true and unrelated?” Annals of Surgical Oncology, vol. 7, no. 1, pp. 2–3, 2000. View at Publisher · View at Google Scholar
  16. J.-M. Coindre, P. Terrier, N. B. Bui et al., “Prognostic factors in adult patients with locally controlled soft tissue sarcoma: a study of 546 patients from the French Federation of Cancer Centers Sarcoma Group,” Journal of Clinical Oncology, vol. 14, no. 3, pp. 869–877, 1996. View at Google Scholar
  17. P. W. T. Pisters, D. H. Y. Leung, J. Woodruff, W. Shi, and M. F. Brennan, “Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities,” Journal of Clinical Oncology, vol. 14, no. 5, pp. 1679–1689, 1996. View at Google Scholar
  18. A. Stojadinovic, D. H. Y. Leung, A. Hoos, D. P. Jaques, J. J. Lewis, and M. F. Brennan, “Analysis of the prognostic significance of microscopic margins in 2,084 localized primary adult soft tissue sarcomas,” Annals of Surgery, vol. 235, no. 3, pp. 424–434, 2002. View at Publisher · View at Google Scholar
  19. C. S. Trovik, H. C. F. Bauer, T. A. Alvegård et al., “Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register,” European Journal of Cancer, vol. 36, no. 6, pp. 710–716, 2000. View at Publisher · View at Google Scholar
  20. B. P. Whooley, J. F. Gibbs, M. M. Mooney, B. E. McGrath, and W. G. Kraybill, “Primary extremity sarcoma: what is the appropriate follow-up?” Annals of Surgical Oncology, vol. 7, no. 1, pp. 9–14, 2000. View at Publisher · View at Google Scholar
  21. L. Moureau-Zabotto, L. Thomas, B. N. Bui et al., “Management of soft tissue sarcomas (STS) in first isolated local recurrence: a retrospective study of 83 cases,” Radiotherapy and Oncology, vol. 73, no. 3, pp. 313–319, 2004. View at Publisher · View at Google Scholar
  22. R. C. Ramanathan, R. A’Hern, C. Fisher, and J. M. Thomas, “Prognostic index for extremity soft tissue sarcomas with isolated local recurrence,” Annals of Surgical Oncology, vol. 8, no. 4, pp. 278–289, 2001. View at Publisher · View at Google Scholar
  23. A. N. van Geel, U. Pastorino, K. W. Jauch et al., “Surgical treatment of lung metastases: the European organization for research and treatment of cancer-soft tissue and bone sarcoma group study of 255 patients,” Cancer, vol. 77, no. 4, pp. 675–682, 1996. View at Publisher · View at Google Scholar
  24. M. R. Weiser, R. J. Downey, D. H. Y. Leung, and M. F. Brennan, “Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma,” Journal of the American College of Surgeons, vol. 191, no. 2, pp. 184–191, 2000. View at Publisher · View at Google Scholar
  25. K. G. Billingsley, M. E. Burt, E. Jara et al., “Pulmonary metastases from soft tissue sarcoma: analysis of patterns of disease and postmetastasis survival,” Annals of Surgery, vol. 229, no. 5, pp. 602–612, 1999. View at Publisher · View at Google Scholar
  26. A. G. Casson, J. B. Putnam, G. Natarajan et al., “Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma,” Cancer, vol. 69, no. 3, pp. 662–668, 1992. View at Publisher · View at Google Scholar
  27. M. van Glabbeke, A. T. van Oosterom, J. W. Oosterhuis et al., “Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens—a European organization for research and treatment of cancer soft tissue and bone sarcoma group study,” Journal of Clinical Oncology, vol. 17, no. 1, pp. 150–157, 1999. View at Google Scholar